APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -7.5% | 10,998 | +121.6% | 0.03% | -11.1% |
| Q2 2023 | $452 | +10.5% | 4,963 | -20.0% | 0.04% | +20.0% |
| Q1 2023 | $409 | -8.1% | 6,207 | -27.9% | 0.03% | -18.9% |
| Q4 2022 | $445 | -99.9% | 8,604 | +22.0% | 0.04% | -17.8% |
| Q3 2022 | $482,000 | 0.0% | 7,050 | -33.8% | 0.04% | +2.3% |
| Q2 2022 | $482,000 | +53.0% | 10,651 | +71.9% | 0.04% | +340.0% |
| Q1 2022 | $315,000 | – | 6,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |